Concentrix (NASDAQ:CNXC) Releases FY 2026 Earnings Guidance

Concentrix (NASDAQ:CNXC) issued an update on its FY 2026 earnings guidance on Monday morning. The company provided earnings per share guidance of 10.830-11.180 for the period, compared to the consensus estimate of 11.450. The company issued revenue guidance of $9.9 billion-$10.0 billion, compared to the consensus revenue estimate of $10.1 billion. Concentrix also updated its Q3 2026 guidance to 2.650-2.770 EPS.

Concentrix Stock Performance

CNXC stock traded up $0.23 during midday trading on Monday, reaching $25.23. 3,077,140 shares of the company were exchanged, compared to its average volume of 1,607,306. The company has a debt-to-equity ratio of 1.43, a current ratio of 1.18 and a quick ratio of 1.18. The business has a 50-day moving average price of $25.93 and a two-hundred day moving average price of $32.17. Concentrix has a one year low of $22.05 and a one year high of $62.14. The firm has a market capitalization of $1.54 billion, a price-to-earnings ratio of -1.17, a price-to-earnings-growth ratio of 0.31 and a beta of 0.43.

Analyst Ratings Changes

Several research firms have weighed in on CNXC. Barrington Research reissued an “outperform” rating and issued a $38.00 price target on shares of Concentrix in a report on Monday, June 22nd. Canaccord Genuity Group reduced their price objective on Concentrix from $80.00 to $55.00 and set a “buy” rating for the company in a report on Wednesday, March 25th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Concentrix in a research report on Monday, April 27th. Robert W. Baird lowered their target price on Concentrix from $52.00 to $40.00 and set an “outperform” rating on the stock in a research note on Wednesday, March 25th. Finally, Wall Street Zen cut Concentrix from a “buy” rating to a “hold” rating in a report on Saturday, March 28th. Three investment analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $44.33.

Insider Activity

In other Concentrix news, major shareholder Bruxelles Lambert Groupe sold 6,000,000 shares of the business’s stock in a transaction dated Wednesday, April 29th. The shares were sold at an average price of $22.25, for a total value of $133,500,000.00. Following the completion of the sale, the insider owned 2,773,667 shares of the company’s stock, valued at $61,714,090.75. The trade was a 68.39% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CFO Andre S. Valentine acquired 2,500 shares of the business’s stock in a transaction on Thursday, April 9th. The stock was acquired at an average cost of $27.95 per share, with a total value of $69,875.00. Following the acquisition, the chief financial officer directly owned 89,066 shares in the company, valued at approximately $2,489,394.70. This trade represents a 2.89% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. 0.90% of the stock is owned by insiders.

Institutional Investors Weigh In On Concentrix

Large investors have recently added to or reduced their stakes in the stock. Sivia Capital Partners LLC increased its position in shares of Concentrix by 34.4% in the second quarter. Sivia Capital Partners LLC now owns 6,283 shares of the company’s stock worth $332,000 after purchasing an additional 1,607 shares during the period. Corient Private Wealth LLC bought a new stake in Concentrix during the fourth quarter worth about $289,000. Deutsche Bank AG lifted its position in Concentrix by 4.7% during the fourth quarter. Deutsche Bank AG now owns 6,767 shares of the company’s stock worth $281,000 after purchasing an additional 303 shares during the period. Orion Porfolio Solutions LLC grew its stake in Concentrix by 7.5% during the third quarter. Orion Porfolio Solutions LLC now owns 5,679 shares of the company’s stock worth $262,000 after buying an additional 398 shares in the last quarter. Finally, Creative Planning acquired a new stake in Concentrix during the second quarter worth about $251,000. Institutional investors and hedge funds own 90.34% of the company’s stock.

About Concentrix

Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.

Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.